| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $9.7M | — | -27.3% |
| Cost of Revenue | $8.0M | — | -15.2% |
| Gross Profit | $1.7M | — | -56.5% |
| R&D Expense | $980K | — | -2.0% |
| SG&A Expense | $4.5M | — | -29.5% |
| Operating Income | -$5.7M | — | +3.2% |
| Pre-tax Income | -$6.6M | — | +2.5% |
| Net Income | -$6.6M | — | +2.5% |
| EPS (Basic) | -$0.64 | — | +31.2% |
| EPS (Diluted) | -$0.64 | — | +31.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $8.6M | -52.7% | +208.1% |
| Accounts Receivable | $3.0M | -29.3% | -29.5% |
| Inventory | $24.3M | +0.3% | +11.8% |
| Current Assets | $40.0M | -20.4% | +19.5% |
| Total Assets | $75.7M | -12.5% | +2.0% |
| Current Liabilities | $16.6M | -16.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$8.8M | — | -94.7% |
| Capital Expenditures | $279K | — | -64.1% |
| Investing Cash Flow | -$279K | — | +64.1% |
| Financing Cash Flow | -$570K | — | -117.6% |
| Free Cash Flow | -$9.1M | — | -71.4% |
| -32.1% |
| Long-term Debt | $19.1M | -1.2% | -78.7% |
| Total Liabilities | $48.9M | -7.3% | -43.7% |
| Stockholders' Equity | $3.9M | -66.1% | +125.0% |